Clinical trial
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not…
NCT00005811 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005811 |
|---|---|
| Title | Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment |
| Official title | A Phase II Study of Intrathecal Topotecan (NSC #609699) in Patients With Refractory Meningeal Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma, AIDS-related Lymphoblastic Lymphoma, AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, AIDS-related Small Noncleaved Cell Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma and 11 more |
| Intervention type | Drug, Other |
| Interventions | topotecan hydrochloride, laboratory biomarker analysis |
| Enrollment | 77 |
| Start date | Apr 1, 2000 |
| Primary completion | Apr 1, 2006 |
| Completion | Feb 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: